Jump to main content
Jump to site search

Issue 23, 2011
Previous Article Next Article

Multimodality and nanoparticles in medical imaging

Author affiliations


A number of medical imaging techniques are used heavily in the provision of spatially resolved information on disease and physiological status and accordingly play a critical role in clinical diagnostics and subsequent treatment. Though, for most imaging modes, contrast is potentially enhanced through the use of contrast agents or improved hardware or imaging protocols, no single methodology provides, in isolation, a detailed mapping of anatomy, disease markers or physiological status. In recent years, the concept of complementing the strengths of one imaging modality with those of another has come to the fore and been further bolstered by the development of fused instruments such as PET/CT and PET/MRI stations. Coupled with the continual development in imaging hardware has been a surge in reports of contrast agents bearing multiple functionality, potentially providing not only a powerful and highly sensitised means of co-localising physiological/disease status and anatomy, but also the tracking and delineation of multiple markers and indeed subsequent or simultaneous highly localized therapy (“theragnostics”).

Graphical abstract: Multimodality and nanoparticles in medical imaging

Back to tab navigation

Publication details

The article was received on 29 Nov 2010, accepted on 02 Feb 2011 and first published on 14 Mar 2011

Article type: Perspective
DOI: 10.1039/C0DT01656J
Dalton Trans., 2011,40, 6087-6103

  •   Request permissions

    Multimodality and nanoparticles in medical imaging

    W. Huang and J. J. Davis, Dalton Trans., 2011, 40, 6087
    DOI: 10.1039/C0DT01656J

Search articles by author